For decades, the dietary supplement aisle has been dominated by three formats: capsules, tablets, and powders. They work. They're familiar. But they all share one inconvenient truth — they require water, they can be difficult to swallow, and a significant portion of the active ingredients they carry never makes it into the bloodstream intact.
A new delivery format is challenging that status quo. Oral dissolving films — ultra-thin, edible strips that dissolve on the tongue in seconds — are moving from the pharmaceutical world into the supplement mainstream. And the timing could not be better.
![]()
The global oral thin films market was valued at approximately $5.58 billion in 2025 and is projected to reach $16.24 billion by 2034, growing at a compound annual growth rate of 12.59% during the forecast period-. Another estimate places the oral dissolving film market at $0.43 billion in 2026, climbing to $0.98 billion by 2035 at a 9.6% CAGR-5.
The numbers vary depending on how the market is defined, but the direction is unmistakable. What was once a niche dosage form — think Listerine breath strips — has evolved into a genuine delivery platform. In 2025 alone, global production capacity for oral disintegrating strips reached an estimated 3.0 billion strips, with total sales volume hitting 2.69 billion units-1.
The nutraceutical segment is the fastest-growing sub-category within this market. Brands are discovering that the format offers something capsules and powders cannot: a genuine bioavailability advantage, a premium visual identity on digital shelves, and a consumer experience that encourages daily compliance-35.
The science behind oral dissolving films is straightforward. When a strip is placed on the tongue or oral mucosa, it hydrates rapidly and releases its active ingredients. A portion of those ingredients can be absorbed directly through the mucosal tissue, bypassing the hepatic first-pass metabolism that degrades a significant percentage of orally ingested compounds before they reach systemic circulation-.
This is not a marginal difference. Studies on oral fast-dissolving films have demonstrated relative bioavailability improvements of up to 178% compared with conventional tablets for certain compounds-. For botanical extracts with notoriously poor oral absorption — and there are many — this represents a meaningful step forward.
The format also solves practical problems. No water required. No swallowing difficulties. No measuring or mixing. For older adults, children, and anyone who has ever choked on a horse-sized capsule, the appeal is immediate.
![]()
The most interesting developments in this space are not happening in the pharmaceutical arena — they're happening in the supplement aisle, where formulators are pairing the oral film format with botanical ingredients that have deep traditional roots and growing scientific backing.
Consider a formulation that combines three botanicals: Shilajit extract (standardized to a 10:1 ratio, equivalent to 10,000mg of raw Shilajit powder), Ashwagandha root extract (from a 10:1 concentrate), and Burdock root extract (also 10:1). Each ingredient brings a distinct set of actions to the table.
Shilajit, a resinous exudate that seeps from rock formations in the Himalayas, has been used in Ayurvedic medicine for centuries. Its principal bioactive constituents — fulvic acid and a complex of urolithin metabolites, phenolic acids, and flavonoids — are proposed to enhance mitochondrial ATP synthesis, attenuate exercise-induced muscle damage, and modulate androgen biosynthesis-48.
A 2026 randomized, double-blind, placebo-controlled trial involving 100 resistance-trained males found that 90 days of standardized Shilajit resin supplementation produced robust improvements in muscle strength and endurance. Maximal leg press strength increased by 26.0% in the active group versus 18.4% in placebo, while muscle endurance improved by 110.8% compared with 80.5%-46. Free testosterone rose 21.8% in the supplemented group, and markers of muscle damage — creatine kinase and lactate dehydrogenase — declined significantly-46.
Ashwagandha (Withania somnifera), often called Indian ginseng, is one of the most extensively studied adaptogens in the world. Its primary active compounds, withanolides, have been linked to reduced cortisol levels, improved stress resilience, and enhanced physical performance. KSM-66®, a proprietary full-spectrum root extract, has been the subject of 24 clinical studies involving nearly 900 participants, with bioavailability that outperforms conventional ashwagandha preparations-.
Burdock root (Arctium lappa) rounds out the formulation. Traditional systems of medicine have long used burdock for its purported blood-purifying and detoxifying properties. Modern research has identified antidiabetic, hypolipidemic, anti-inflammatory, and antioxidant activities in burdock root extract-. A 16-week intervention study in elderly women with metabolic syndrome found that burdock root supplementation, with or without exercise, independently improved abdominal obesity and sex hormone profiles-.
The combination is not arbitrary. Shilajit and Ashwagandha are a classic Ayurvedic pairing — one traditionally used for vitality and physical energy, the other for stress modulation and hormonal balance. Burdock root adds a complementary dimension, supporting metabolic and inflammatory pathways that often undermine long-term progress.
![]()
Oral dissolving strip supplements are regulated as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA) of 1994, provided they contain dietary ingredients as defined in 21 USC 321(ff) and do not bear drug claims-.
In practice, this means manufacturers must operate under current Good Manufacturing Practices (cGMP) and comply with 21 CFR Part 111. Structure/function claims — statements about how a nutrient supports normal body structure or function — are permitted without FDA pre-approval, provided they are truthful, substantiated by competent and reliable scientific evidence, and accompanied by the required disclaimer-35.
The format itself is well-established in regulatory terms. South Korean manufacturers have been producing oral dissolving supplement strips for years, and at least one major player has recently opened a dedicated manufacturing facility in Northern California, investing over a year in construction to meet FDA, cGMP, state, and county standards-31. The technology is proven. The regulatory pathway is clear. The question is no longer whether oral film supplements will enter the mainstream — it is how quickly they will get there.
The oral film supplement category is still young, and that youth cuts both ways. On one hand, it means first-mover advantage is real. Very few supplement brands have established oral film product lines, and the digital shelf is not yet saturated the way it is with capsules and gummies-35. Strip packaging photographs well, differentiates strongly in e-commerce thumbnails, and communicates innovation at a glance.
On the other hand, the category is vulnerable to inconsistent quality. Because films look similar, consumers may not immediately distinguish between a well-formulated product and a poorly made one. Stability, mouthfeel, dissolution behavior, and aftertaste are decisive — and getting them right requires genuine formulation expertise, not just a contract manufacturer willing to run a batch-1.
The brands that will win are those that treat the format as a delivery system, not a gimmick. That means investing in taste-masking architecture, ensuring content uniformity at low active loads, and selecting ingredients that genuinely benefit from mucosal absorption.
For consumers, the upside is clear: a supplement that is easier to take, potentially better absorbed, and more likely to be taken consistently. For the industry, the rise of oral dissolving films represents something rarer — a format innovation that actually delivers on its promises.
The capsule had a good run. The strip is just getting started.